SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: art slott who wrote (506)12/31/1997 3:45:00 PM
From: vestor   of 1837
 
This is my first post. We are an investment group with about 15,000 shares of DRMD. We see good potential for a significant move on the upside in '98. At last check we count 9 drug applications before the FDA, one as an NDA. This recent approval should be the start of several approvals we see coming thru in '98. The block buster will be the NDA, Cnestin. We are aggressive buyers to $5.25. We too expect Cenestin to be approved sometime in the 1st. qtr of '99. However the time table at the FDA is quite unpredictable. I view any significant retracement as a buying opportunity. However it is still not for the faint-of-heart. But the faint-of-heart are usually not the sucessful.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News